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Anecdotes of unexpected or paradoxical mental lucidity
in the days and weeks before death among people with
longstanding dementia have been reported over the last
two centuries, with sparse scientific investigation. For the
purposes of this article, paradoxical lucidity (PL) refers to
an episode of unexpected, spontaneous, meaningful, andde equal contributions to the manuscript.
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commons.org/licenses/by-nc-nd/4.0/).relevant communication or connectedness in a patient who
is assumed to have permanently lost the capacity for
coherent verbal or behavioral interaction due to a progres-
sive and pathophysiologic dementing process. Here, we
focus on PL in the context of persons with dementia when
coherent verbal or behavioral interaction capacity has been
documented as being lost by observers (family members,
caregivers, health professionals, and/or others). We include
all progressive dementias in this consideration that have
a presumed or confirmed neurodegenerative etiology.
If this phenomenon of PL is systematically examined
and confirmed in persons with dementia due to
neurodegeneration, our hypothesis is that the currentimer’s Association. This is an open access article under the CC BY-NC-ND
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process of structural neuropathology must be revised to
include a reversible and functional aspect of pathophysi-
ology, even at late stages. To explore this possibility, the
National Institute on Aging convened a workshop in June
2018 to review evidence for and against the existence of
PL and to obtain input on a research agenda. Investigators
with expertise in PL, dementia, neurology, geriatrics, psy-
chiatry, nursing, neurobiology, consciousness, ethics, lin-
guistics, and clinical research methodology were
represented at the workshop. Here, we present the current
state of the evidence, review relevant research on the phe-
nomenon of PL as well as its biological plausibility, draw
connections across the evidence base to begin to formulate
a mechanistic model, discuss associated ethical issues, and
provide recommendations for a future research agenda.
The ultimate implications of this line of investigation relate
to a fundamental reconsideration of the neurobiology and
care of patients with dementias.2. What is known about PL
Cognitive fluctuations in patients with dementia have
been observed and documented, but usually in patients
with early or moderate stages of the disease [1]. Nahm
et al. [2–4] have collected literature reports, and Batthyany
[5] collected reports from a 12-month retrospective survey
among physicians, nurses, and care providers, usually based
on the time shortly before the death of patients. As these
studies focused on the time around death, the phenomenon
in this context is sometimes called terminal lucidity [2–4],
but here, we will retain the designation of PL. Anecdotal
reports of dramatic fluctuations of cognitive abilities in
severe neurodegenerative diseases that were seemingly not
related to dying can be found in nonacademic sources;
a population-based study of lucid episodes in patients with
severe dementia also contained no mention of episodes
that appeared to be specifically related to the death of pa-
tients [6]. PL is also reported in patients with tumors, brain
abscesses, strokes, and meningitis [3,4], as well as in
comatose patients who awaken shortly before dying [7,8].
Our focus here, however, is on cases involving severe
dementia and includes the following considerations related
to timing and duration.
In a sample of 49 cases, many with dementia, 43% of PL
episodes occurred within the last day of life, 41% within
2-7 days before death, and 10% within 8–30 days before
death [2]. In the enhanced case collection by Nahm [3],
PL in patients with dementia seems to take place predomi-
nantly within 1–2 days before death. This is consistent
with Batthyany’s study [9] of patients with dementia. Of
38 case descriptions, 44% occurred within 1 day before
death, 31% within 2–3 days, and 6% within 4–7 days before
death. Similarly, in a study of end-of-life experiences, seven
out of ten caregivers in a nursing home reported that they hadobserved patients with dementia and confusion becoming
lucid a few days before death during the past five years [10].
Of the 38 cases collected by Batthyany [5], 3% of
the lucid episodes lasted less than 10 minutes, 16% lasted
10–30 minutes, 24% lasted 30–60 minutes, 29% lasted
several hours, 11% lasted one day, and 5% lasted several
days. Nevertheless, episodes of PL may also be brief, lasting
only a few seconds, and the patients may only speak a few
words that express something meaningful of relevance to a
given situation. Hence, PL displays a considerable range
of degree and variety. Lucid episodes that occur shortly
before death may be accompanied by so-called deathbed vi-
sions, for example, visions of deceased loved ones [11].
There is a lack of systematic studies to assess the neuro-
logic underpinnings as well as the epidemiology and
phenomenological characteristics of lucid intervals among
patients with severe dementia [12]. Similarly, although in-
struments to assess fluctuations of cognitive abilities of pa-
tients with dementia exist [13], a specific scale to describe
the extent and qualitative aspects of lucid episodes occurring
late in disease progression is not yet available.3. Related phenomena
There are numerous phenomena related to PL in dementia
that have been more extensively investigated, might provide
mechanistic insight, and might argue for biological plausi-
bility. The near-death experience (NDE) and unexpected
arousal phenomena share the ostensibly paradoxical nature
of PL but often have systems neuroscience explanations.
In this section, we will consider NDEs and other phenomena
of unexpected behavioral recovery or experience.
NDEs have been reported across cultures since antiquity
and are arguably the phenomena most closely aligned with
PL in dementia, especially when the latter occurs just before
death. NDEs represent phenomenologically rich experiences
in the setting of clinical death or a hypofunctioning brain
[14–16]. Similar to PL in dementia, NDEs were primarily
reported anecdotally, retrospectively, or in case studies
until the early 2000s. In 2001, two prospective
epidemiological studies in cohorts of patients who had
cardiac arrest revealed that the incidence of NDEs in this
population could be as high as 18% [17,18], which is
substantially more common than that might have been
predicted from case reports alone. There are a number of
general hypotheses regarding physiologically based
etiologies of NDEs, including a rapid eye movement
sleep-like state [19] or endogenous release of hallucinogen
[20].
It has been reported that dying patients in the critical care
or operative setting can exhibit a surge of electrical activity
in frontal montage electroencephalography [21–23].
However, the relevance of this electrical surge to the
phenomenology of the NDE is unclear because such
electrical surges could reflect nothing more than a
nonspecific discharge attributable to the uncoordinated
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associated with hypoxia and loss of membrane integrity.
Experiments in a rodent model of both cardiac and
respiratory arrest replicated the frontal surge of electrical
activity but further demonstrated increased functional and
directional connectivity between frontal and posterior
cortices that were similar to neural correlates of
consciousness identified in humans [24]. Follow-up studies
in rodents have confirmed this surge of large-scale cortical
communication after cardiac arrest and have detailed associ-
ated neurochemical surges [25]. The progression of NDE
investigation from anecdote to case report to epidemiology
to mechanistic investigation could be informative for future
research programs of PL in dementia.
There are other forms of paradoxical improvements in
cognitive function or arousal of possible relevance to PL.
For example, the sleep-promoting drug zolpidem has been
shown to enhance arousal and behavioral recovery in pa-
tients in a vegetative state [26]. Zolpidem appears to cause
what has been referred to as paradoxical metabolic and
vascular changes [27,28]. However, such changes have
been explained in the context of a mesocircuit model of
disordered consciousness [29]. Similarly, children with
autism have been found to show signs of recovery across a
number of domains in the setting of fever [30]. These two sit-
uations (zolpidem in vegetative states and fever in autism)
share the common feature of a disordered neural network
that recovers function after a perturbation that would typi-
cally have a depressive or disorganizing effect in the normal
brain.
There has been recent work in anesthetic-induced uncon-
sciousness reporting a phenomenon that has been referred to
as paradoxical emergence. In animals anesthetized with iso-
flurane, the addition of the intravenous anesthetic ketamine
induces a deeper state of unconsciousness (as indicated by
the appearance of burst suppression) [31]. However, despite
the deeper state of anesthesia, the animals treated with keta-
mine recover from unconsciousness 44% faster than con-
trols. This ostensible paradox, that is, an intervention that
more profoundly disables the brain but allows it to recover
function more quickly, was associated with enhanced
cholinergic tone in the prefrontal cortex. A follow-up study
demonstrated that agonizing acetylcholine receptors in the
prefrontal cortex could actually reverse the anesthetized
state despite the ongoing administration of inhaled general
anesthetics [32]. This return of function in the setting of clin-
ical levels of general anesthetic in the brain has also been ex-
plained through a mesocircuit model, prominently involving
the cholinergic system of the basal forebrain [33].
It is also important to note that there is evidence for
preserved consciousness and selfhood in the setting of
ostensibly devastating structural brain damage. For example,
patients with a diagnosis of vegetative state exhibit
such covert consciousness, losing the ability to interact
behaviorally with the world but able to demonstrate volition
through brain activity, which is identified through functionalmagnetic imaging [34]. It is thus conceivable that patients
with dementia could, in some cases, have a preserved self
with the inability to engage behaviorally except in sporadic
cases such as PL.
In summary, there are phenomena that, similar to PL in
dementia, represent an unexpected or ostensibly paradoxical
recovery of neural function with a systems neuroscience
explanation. In the next section, we speculate as to how
the neurobiology of these related phenomena, which have
been studied more extensively, might inform the mechanistic
understanding of PL in severe dementia.4. Possible mechanisms of PL
Several forms of dementia, including Alzheimer’s de-
mentia, are largely associated with irreversible degeneration
of the cerebral cortex and the hippocampus, resulting in
confusion, disorientation, and memory loss, among other
symptoms [35,36]. Because the episodes of PL occur
rather suddenly, it is unlikely that regeneration of neurons
can account for them. Such fluctuations may reflect
complex adjustments in signaling cascades, synaptic
modifications, neuronal network interactions, and, perhaps,
temporary reversal of, or compensation for, chronic
functional inhibition due to neurotoxic proteins [37]. We
acknowledge that there are different modes of cognitive fluc-
tuation in varying types of dementia [38,39], such as
dementia with Lewy bodies. As noted in the Introduction,
our focus is on the dramatic behavioral recovery at the
timewhen the functional consequences of the neurodegener-
ation are thought to be irreversible, although a more compre-
hensive understanding of mechanisms of cognitive
fluctuation across the full disease course for a range of de-
mentias is lacking.
There have been no neuroscientific studies of PL, and
thus, any mechanistic framework must be considered specu-
lative. However, the related phenomena described previ-
ously speak to the biological possibility of PL and provide
some insight into a potential mechanism. Because episodes
of PL often occur just before death, the emerging neurobio-
logical data related to NDEs are of relevance. As noted,
surges of neurophysiological activity have been observed
in humans just before death in the critical or operative care
setting [21–23] and in experimental rodent models after
cardiac or respiratory arrest [24]. It is thus conceivable
that some patients with severe dementia might also experi-
ence a surge of neurophysiological activity before death,
which is manifested as a lucid episode. Furthermore, extrap-
olating from studies of rats assessing neurochemistry after
two minutes of asphyxia [25], it is possible that as oxygen
and glucose levels fall or fluctuate, there is a surge of neuro-
transmitter levels that results in transient or metastable acti-
vation of the brain. However, such surges of electrical
activity or neurotransmitter release do not explain how there
can be enhanced synchronization or communication across
the brain, which has been observed in dying rats and
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cogent behavior in a patient with severe dementia. A
network-level explanation is likely required.
The dynamics of complex networks are of relevance to
neural function and have longbeen studied in the field of phys-
ics. There are precedents for the spontaneous recovery of
nonbiological networks after periods of inactivity or damage
[40]. In fact, network concepts related to “amplitude death”
and “oscillation death” might be applicable to the observed
surge in neurophysiological coherence just before functional
network breakdown in the brain around the time of death. Us-
ing a Stuart-Landau model, one investigation described the
dynamics of how such oscillations can spontaneously
“revive,” [41] while another study described how the revival
of such oscillations can be accompanied by rhythmicity and
dynamic activity across the network [42]. These concepts
have also been instantiated in neuronal models, with the
conclusion that at a certain point of neuronal inhibition in a
sparsely connected network, there is a counterintuitive
“rebirth” of neuronal activity [43] that is manifested across
the network. Furthermore, conditions for rapid and nonlinear
synchronization (sometimes referred to as “explosive syn-
chronization”) occur in association with arousal when brain
network hubs are suppressed [44], as in dementia [45].
Thus, although the mechanism of PL is unknown, there is
evidence that the dying or hypoxic brain can generate neuro-
chemical and neuroelectrical surges that might be associated
with the network dynamics of complex systems and that
might generate spontaneous network integration manifest-
ing as lucid behavior. We emphasize that this is speculative,
but computational modeling studies of large-scale brain net-
works, which have been applied to Alzheimer’s disease,
could be investigated to establish foundational credibility
for such network phenomena in those with severe dementia.
It must also be noted that there may not be a unique mecha-
nism for PL that is restricted to the days before death but
rather a mechanism that is common to cognitive fluctuations
in less severe stages of the disease [12,13]. Furthermore,
changes in systemic factors, rather than intrinsic neural
dynamics, might drive the causal mechanisms responsible
for lucid episodes. For example, one case report of a
patient with Parkinson’s disease dementia was able to
correlate cognitive fluctuations with paroxysmal episodes
of hypotension [46]. Thus, systemic physiologic factors
must also be considered in the mechanism of PL.5. Ethical considerations
In addition to its important neurobiological implications,
PL has important ethical implications. Persons with severe
dementia are vulnerable, a term that describes a state of being
absolutely or relatively incapable of protecting one’s rights
and interests. One cause of vulnerability is the lack of
adequate decisional capacity. Impairments in expressive lan-
guage may hinder the person’s ability to state a choice, and
impairments in memory and executive function may causeinadequate understanding or appreciation [47]. As a result,
the person may be unable to provide an informed consent to
participate in a research study related to PL. Another cause
of vulnerability is residence in a long-term-care facility.
The person is, in a sense, confined and so unduly influenced
by the will of those who run the institution. Substantial
ethics scholarship has worked out means to address such
causes of vulnerability [40,48]. They include thresholds of
permissible research risk called minimal risk, standards for
proxy informed consent, and processes for the review and
approval of research that involves persons who live or work
in long-term-care facilities. Scientists and institutional review
boards can also draw on prior studies of persons with severe
dementia as precedents upon which they can assess the risks
and benefits of studies focused on PL, including neuroimag-
ing in personswith severe dementia near the end of life [49] or
testing of pharmaceuticals to modify behavior [50,51].
Research and clinical translation related to PL should
draw on an ethical framework. Much of the ethics of care
for a person with severe dementia is captured in a framework
that recognizes the need to respect the person’s “then” and
“now” selves [52]. The “then self” describes the values
and preferences the person had before dementia or in the
early stages of the disease. Some persons record these pref-
erences in documents such as living wills. The “now self”
describes the person with more advanced dementia who
has distinctly different values and preferences or an inability
to express them than when they did not have disabling cogni-
tive impairments. PL arguably closes this tension. An aspect
of the “then self” is being presented by the “now self.” Future
investigators will have to better understand how the observa-
tion of PL affects the social and emotional reactions of peo-
ple who care for a person with dementia and, as a result, the
ways in which they care for the person. As we gain insight
into the pharmacology and neurobiology of PL, well-
intentioned families, researchers, and clinicians eager to
bring out the “then self” may experience a zeal to try out in-
terventions to foster the frequency and intensity of its occur-
rence. This attitude could distort expectations of benefit to a
degree that they misunderstand or fail to appreciate the inter-
vention’s burdens, risks, and uncertainties.6. Developing a research program
The current state of understanding the phenomenon of PL
is limited to anecdote and case study and is subject to selec-
tion bias and recall bias. For PL to represent a critical
counter-instance that challenges current paradigms of de-
mentia, systematic research must be conducted. To date,
there are few studies of PL or related forms of lucidity
[1,6], and there are limitations to the current literature.
Validation of family and staff experiences of lucidity when
it occurs is a desirable goal of practice, but there is a need
to clearly define the phenomenon of PL to distinguish
between what family and staff may refer to as a “good
day” due to dramatically and unexpectedly improved
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behavior [53–55]. Similarly, there is a need to distinguish
between lucidity and cognitive fluctuations associated with
improved attention and alertness that may accompany
certain types of dementia (e.g., Lewy body dementia) [12]
or delirium resolution [56], but that do not necessarily reflect
unexpected levels of cognitive functioning constituting a
challenge to current conceptions of dementia.
Given the paucity of literature on PL in dementia, its
systematic study poses a number of challenges and opportu-
nities around the use of quantitative and qualitative methods
that can describe the phenomenon and its neurobiology,
identify potential research participants and settings, and
develop valid instruments and technology for data capture.6.1. Methods for characterizing the phenomenon
Before PL in dementia can be measured or evaluated, it is
essential to definewhat it is to bemeasured. It is also important
to consider what measurement strategiesmight be appropriate
for defining what is currently known as a poorly characterized
phenomenon. Two distinct but related approaches are relevant
to the measurement of PL in dementia: the clinimetric and the
psychometric approaches [50,57]. Clinimetrics is the science
of measuring clinical phenomena using expert judgment for
the construction of a short and useful clinical index (a
heterogeneous set of indicators) that carries face validity. An
example of this approach is the development of the Apgar
score for assessing neonates. The clinimetric approach,
while less familiar to investigators, can advance a field,
especially during early stages of measurement development.
Psychometric measurement development is the more
traditional approach and involves statistical methods (i.e.,
factor analysis, latent class analysis) that are guided by
theory and clinical insight. These measurements are
rigorously defined, designed, and used to develop evidence
of the construct validity of the theoretical concept.
In addition to the measurement strategy used, several
qualitative research methods may be of use in describing
PL in dementia itself as well as how this phenomenon is
experienced by patients, family, and clinicians. The Delphi
method offers a systematic means of determining expert
consensus on a phenomenon for which there are not much
data available and/or which does not lend itself to experi-
mental methods [58]. Potential uses of the Delphi method
to explore PL in dementia include (1) defining it as a foun-
dational concept, for example, how should we define PL?
(2) making estimations given incomplete evidence, for
example, what is the likely global prevalence? (3) making
predictions, for example, what increases an individual’s
chance of experiencing PL in dementia? and (4) determining
collective values, for example, what aspects of PL in demen-
tia should be prioritized for study? A strength of this method
is that experts can draw on available evidence as well as
their professional and personal experience to contribute to
a shared definition [58].6.2. Methods for explaining the phenomenon
An incompletely characterized phenomenon such as PL re-
quires qualitative andquantitative exploration.Beyond charac-
terizing the lucidity experience and the scope of its expression,
a research agenda should also include (1) establishing preva-
lence estimates; (2) identifying settings and sources of infor-
mation; (3) identifying methods for combining observational
data with those from imaging, pathology, and neurobiology;
(4) determining optimal methods for end-user involvement
in investigations; and (5) using appropriate methods for data
capture. As most cases have been reported at the end of life,
long-term-care facilities are a logical setting for its study [4].
Research to establish prevalence might begin with staff esti-
mates based on a predetermined sampling frame of nursing
homes, hospices (facility-based and in-home), and “hospital
at home” programs [59]. In the United States, for example,
there are approximately 15,640 nursing homes that care for
1.4 million people, 65% ofwhom have dementia [60]. In addi-
tion, 70% of people with dementia die in these nursing homes
[61]. Consistent assignment of nursing home staff is a best
practice in higher quality settings because it gives staff the op-
portunity to become familiar with residents over an extended
period. Thus, instances of lucidity might be more readily
observed in these settings that follow this practice [62,63].
Another potential opportunity for the study of PL in demen-
tia is to link research questions to networks for the study of
neurodegenerative diseases such as the 27 National Institute
on Aging–funded Alzheimer’s Disease Centers [64] or the
GermanCenter forNeurodegenerativeDiseases [65]. These in-
terconnected centers have exponentially increased our under-
standing of neurodegenerative diseases by systematically
following up well-characterized cohorts of individuals living
with dementia. They are rich repositories of longitudinal data
(clinical and biomarker) that could be combined with observa-
tional data and probed for potential causal mechanisms.6.3. Methods for capturing data
Technology can be used to support longitudinal moni-
toring, with the potential for capturing and analyzing epi-
sodes. Both audio and video recording technology can be
used to create an objective record of these events and would
complement qualitative methods. Because most of these rare
episodes are expected to occur toward the end of life,
focusing on capturing data in long-term-care facilities is
likely to be most productive. However, using audio and
video recording technology in long-term-care facilities pre-
sents several technological and logistical challenges.
Technological challenges include selecting and positioning
equipment to maximize data quality and minimize intrusive-
ness on the individual being monitored, for example, care-
givers, roommates, staff, and visitors. Socially assistive
robotic devices have been investigated for use across a range
of dementia severity levels in homes, long-term-care facilities,
and day care facilities [66–68]. These devices could be
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video in addition to their intended therapeutic purpose. Given
that monitoring for lucidity events potentially takes a long
time, automatic speech recognition and audio and video
event detection should be explored for the purposes of
indexing and retrieval of information from recorded data.
The emphasis in evaluating indexing systems should be on
maximizing their sensitivity given the expected low
frequency of episodes.7. Next steps for research and policy
The next steps for systematically characterizing PL could
start with funder support for the development of surveillance
technologies as described previously. Funders can also facil-
itate large-scale observational data collection to standardize
reporting of suspected PL occurrence to advance description
and definition through a newly created registry and/or exist-
ing research networks.
The Alzheimer’s Disease Centers [58], Alzheimer’s Dis-
ease Neuroimaging Initiative [69], Brain Health Registry
(https://www.brainhealthregistry.org/), and other large
comprehensive data-collection efforts in dementia could
add PL surveillance modules. Identification of causal,
permissive, and/or inhibitory mechanisms would greatly
benefit from the longitudinal clinical, genetic, and biomarker
data available through these sources. Measures of cognitive
fluctuation [17] could be included in ongoing longitudinal
studies, helping to establish whether the frequency or quality
of prior cognitive fluctuations relates in any way to PL. Such
psychometric measures can also serve as the basis for further
scale development to enable systematic data collection about
PL from providers and family. Collection of dementia-
relevant and potentially PL-relevant data, for example, on
cardiovascular instability associated with cognitive fluctua-
tion [46], would expand understanding of the phenomenon
while also adding to the knowledge about clinical dementia
syndromes. As noted previously, computational modeling
studies, particularly informed by wider collection of both
structural and functional neuroimaging data, could advance
understanding of the phenomenon.
Next steps also include leveraging citizen science to
encourage individuals to create advance care instructions
regarding PL surveillance. A “lucidity watch” may be stipu-
lated in advance care planning documents, for example, as
individuals may want to capture and optimize the potential
for a meaningful end-of-life event with the potential to con-
nect with the possibility of a premorbid interaction with
loved ones. Patient advocacy organizations as well as fun-
ders could inform these strategies.
Next steps can also extend to examining guidelines
for end-of-life care. Management of pain and agitation
at the end of life would require reconsideration, with the
potential for modified metrics of care quality, should links
between PL and specific clinical and pharmacologic inter-
ventions be identified.8. Conclusion
Unexpected episodes of lucidity occur in patients with
dementia for whom the observed loss of coherent communi-
cation capacity and associated behavioral sequelae are
considered irreversible. If systematically verified, the neuro-
biological implications are that the brain—even in the
setting of severe dementia—is capable of accessing func-
tional networks to generate meaningful communication
and interaction with the world. This would motivate recon-
sideration of current paradigms of dementia, with new ave-
nues in the systems neuroscience approach to therapeutic
intervention. We have provided examples supporting the
biological possibility of paradoxical manifestations of
lucidity as well as systematic and ethical approaches to
future studies. Dementia creates a profound burden for pa-
tients, caregivers, clinicians, and society. Further investiga-
tion of the mechanisms underlying PL is warranted given
the potential for unique insights into the nature of neurode-
generative diseases and the potential for mechanistic expla-
nations that could lead to novel interventions.
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mentia.RESEARCH IN CONTEXT
1. Systematic review: A multidisciplinary panel of ex-
perts reviewed case reports and scientific studies
related to unexpected or paradoxical cognitive
lucidity in patients with severe dementia.
2. Interpretation: Paradoxical lucidity appears to occur,
despite what appear to be irreversible functional lim-
itations, andmight be explained by systems neurosci-
ence and network science.
3. Future directions: Paradoxical lucidity challenges
certain conceptions of severe dementia; the inci-
dence, mechanism, and ethical implications of para-
doxical lucidity warrant further study.
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